Related Experiment Videos
Abdominal Burkitt's lymphoma: role of early aggressive surgery
Insights
Aggressively reducing abdominal Burkitt's lymphoma surgically may not improve survival and can lead to complications. Further multi-institutional studies are needed to review surgical management strategies.
Area of Science:
- Pediatric Oncology
- Surgical Oncology
- Pediatric Surgery
Background:
- Abdominal Burkitt's lymphoma is a pediatric malignancy requiring surgical consideration.
- Current teaching often emphasizes tumor debulking to improve outcomes.
Purpose of the Study:
- To evaluate the effectiveness of aggressive surgical cytoreduction in pediatric abdominal Burkitt's lymphoma.
- To assess the impact of surgical interventions on survival and complications.
Main Methods:
- Retrospective review of 16 pediatric patients with Burkitt's lymphoma.
- Analysis of outcomes based on surgical approach: primary resection, debulking, or incisional biopsy with planned later resection.
Main Results:
- Of 11 patients with abdominal tumors, 5 were long-term survivors and 6 died.
- Primary resection in 3 patients yielded 2 survivors; debulking in 4 patients yielded only 1 survivor.
- Complications included acute renal failure in patients undergoing both primary resection and debulking.
Conclusions:
- This pilot study does not support a clear survival advantage for aggressive surgical cytoreduction in abdominal Burkitt's lymphoma.
- Aggressive debulking may cause severe complications and delay chemotherapy, potentially impacting survival.
- A multi-institutional review is recommended to clarify optimal surgical management strategies.
Abstract:
Current surgical teaching advocates debulking of the abdominal Burkitt's lymphoma to decrease tumor burden and improve survival. The records of 16 children who had Burkitt's lymphoma were reviewed. Eleven of these children presented with abdominal tumors. Five of these 11 patients are long-term survivors and six have died. Three of the tumors were primarily resected; two were in patients who became long-term survivors. One resection was complicated by acute renal failure, leading to the early demise of the patient. Four tumors were debulked; only one of these was in a long-term survivor. Acute renal failure also complicated the hospital course in one of these children. Finally, four patients underwent initial incisional biopsies and plans were made for subsequent resection of any residual tumor 6 weeks later. Two of these children survived and two have died. The results of this pilot study do not confirm that there is a clear advantage to aggressive operative cytoreduction. Although this approach decreases the total tumor burden, it may also impose severe metabolic complications and postpone the administration of chemotherapy. These results do suggest the need for a multi-institutional review of the surgical management of abdominal Burkitt's lymphoma.